Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Ontruzant
MeSH Supplementary Concept Data 2025
Details
Concepts
MeSH Supplementary
Ontruzant
Unique ID
C000631275
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000631275
Entry Term(s)
SB3 antibody
Registry Numbers
0
Heading Mapped to
*Biosimilar Pharmaceuticals
*Trastuzumab
Frequency
3
Note
the first trastuzumab biosimilar approved for routine use in Europe
Source
Future Oncol. 2018 Nov;14(27):2795-2803.
Date of Entry
2019/05/21
Revision Date
2019/05/21
Expand All
Collapse All
Ontruzant
Preferred
Concept UI
M000650091
Registry Numbers
0
Terms
Ontruzant
Preferred Term
Term UI
T000958661
Date
05/21/2019
LexicalTag
TRD
ThesaurusID
NLM (2019)
SB3 antibody
Narrower
Concept UI
M000650092
Terms
SB3 antibody
Preferred Term
Term UI
T000958662
Date
05/21/2019
LexicalTag
LAB
ThesaurusID
NLM (2019)
page delivered in 0.004s